Immunity against COVID-19: Potential role of Ayush Kwath

Immunity against COVID-19: Potential role of Ayush Kwath

SARS-CoV-2 infection associated respiratory disease- COVID-19 has evolved into a pandemic but, being a new form of virus, pathogenesis of disease causation is not fully understood and drugs and vaccines against this virus are still being tested so that no effective drugs or vaccines have been advise...

Full description

Bibliographic Details
Main Authors:	Shankar Gautam, Arun Gautam, Sahanshila Chhetri, Urza Bhattarai
Format:	Article
Language:	English
Published:	Elsevier 2022-01-01
Series:	Journal of Ayurveda and Integrative Medicine
Subjects:	Ayurveda COVID-19 SARS-CoV-2 Coronavirus Immunity Ayush
Online Access:	http://www.sciencedirect.com/science/article/pii/S0975947620300668

Similar Items

Efficacy and safety of AYUSH-64 as standalone or adjunct to standard care in COVID-19: a structured summary of protocol for a systematic review
by: Amit Kumar Rai, et al.
Published: (2022-05-01)

AYUSH- 64: A potential therapeutic agent in COVID-19
by: Ashok Kumar Panda, et al.
Published: (2022-04-01)

Impact of AYUSH 64 as an adjunctive to standard of care in mild COVID 19 - An open-label randomized controlled pilot study
by: Anup Thakar, et al.
Published: (2022-07-01)

Advancing the one health approach through integration of Ayush systems: Opportunities and way forward
by: Shobhit Kumar, et al.
Published: (2023-01-01)

AYUSH digital initiatives: Harnessing the power of digital technology for India’s traditional medical systems
by: Sendhilkumar Muthappan, et al.
Published: (2022-04-01)

Disease Characteristics, Care-Seeking Behavior, and Outcomes Associated With the Use of AYUSH-64 in COVID-19 Patients in Home Isolation in India: A Community-Based Cross-Sectional Analysis
by: Narayanam Srikanth, et al.
Published: (2022-07-01)

A critical analysis of CTRI registered AYUSH studies for COVID- 19
by: Vedvati Bhapkar, et al.
Published: (2022-01-01)

Network pharmacology of AYUSH recommended immune-boosting medicinal plants against COVID-19
by: Pukar Khanal, et al.
Published: (2022-01-01)

In silico evaluation of the compounds of the ayurvedic drug, AYUSH-64, for the action against the SARS-CoV-2 main protease
by: Thrigulla Saketh Ram, et al.
Published: (2022-01-01)

Sensitization of population for preventive measures suggested by AYUSH ministry through development of mobile application “virtual immunity booster:” A prototype research model
by: Danish Javed, et al.
Published: (2023-01-01)

Management approach to Covid-19 associated upper respiratory tract infection in Ayurveda: A review study
by: Gulab Chand Pamnani, et al.
Published: (2020-01-01)

AYUSH 64, a polyherbal Ayurvedic formulation in Influenza-like illness - Results of a pilot study
by: Manohar S. Gundeti, et al.
Published: (2022-01-01)

Report: Council for Ayurveda Research - Industry Roundtable and Global Consortium for Collaborative Research in Ayurveda, 2021
by: Pratibha Shah, et al.
Published: (2022-07-01)

AYUSH'u Hindistan'ın sağlık dağıtım sistemine entegre etmek
by: Saurabh Shrivastava, et al.
Published: (2019-12-01)

Beneficial role of Indian medicinal plants in COVID-19
by: Deepti Chopra, et al.
Published: (2021-01-01)

Jatharagni and Prakriti of young Indian adult population: A descriptive cross-sectional study
by: Meera Kuttikrishnan, et al.
Published: (2022-01-01)

Prevalence and correlates of multimorbidity among patients attending AYUSH primary care settings in Delhi-National Capital Region, India
by: Roja Varanasi, et al.
Published: (2023-11-01)

Evidence Based Validation of Indian Traditional Medicine – Way Forward
by: Pulok K Mukherjee, et al.
Published: (2016-01-01)

Evaluation of Ayush-64 (a Polyherbal Formulation) and Its Ingredients in the Syrian Hamster Model for SARS-CoV-2 Infection Reveals the Preventative Potential of <i>Alstonia scholaris</i>
by: Zaigham Abbas Rizvi, et al.
Published: (2023-09-01)

Perception on effect of AYUSH treatment among patients with selected NCDs at life style diseases clinics from six states of India: Lessons learnt and way forward
by: T P Sherin Raj, et al.
Published: (2023-01-01)

Ratrijagarana night wakefulness and its impact on Manasika Bhava mental characteristics among industrial workers: A descriptive cross-sectional study
by: Elgeena Varghese, et al.
Published: (2022-04-01)

Relevance of Traditional Indian Medical Concepts in Psychosomatic Medicine
by: Mamta Sood, et al.
Published: (2017-07-01)

Exploring AyuGenomics approach for understanding COVID-19 predisposition and progression
by: Vedika Bhat, et al.
Published: (2022-01-01)

Promising Antiviral Activities of Natural Flavonoids against SARS-CoV-2 Targets: Systematic Review
by: Ridhima Kaul, et al.
Published: (2021-10-01)

Impact of MERS-CoV and SARS-CoV-2 Viral Infection on Immunoglobulin-IgG Cross-Reactivity
by: Joud Mohammed AlKhalifah, et al.
Published: (2023-02-01)

Analysis of AYUSH studies registered in clinical trials registry of India from 2009 to 2020
by: M.S. Shree Devi, et al.
Published: (2021-04-01)

Seronegative immunity to SARS-CoV-2: a case study
by: Kyle D. Miller, et al.
Published: (2022-08-01)

Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections?
by: Varnica Bajaj, et al.
Published: (2021-01-01)

Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections
by: Hanaa Ahmed-Hassan, et al.
Published: (2020-08-01)

Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection
by: Zahra Khoshkam, et al.
Published: (2021-07-01)

Bioactive natural compounds against human coronaviruses: a review and perspective
by: Yanfang Xian, et al.
Published: (2020-07-01)

Potential mouse models of coronavirus-related immune injury
by: Fu-Yao Nan, et al.
Published: (2022-09-01)

An open-labelled randomized clinical trial for the evaluation of Balaharidradi Lepa with and without Khadira Twaka Kwath in Vyanga (Melasma)
by: Sukha Ram, et al.
Published: (2021-01-01)

Alkaloids: Therapeutic Potential against Human Coronaviruses
by: Burtram C. Fielding, et al.
Published: (2020-11-01)

Antiviral Activity of Umifenovir In Vitro against a Broad Spectrum of Coronaviruses, Including the Novel SARS-CoV-2 Virus
by: Irina Leneva, et al.
Published: (2021-08-01)

POTENTIAL RISK OF BRAIN DAMAGE AND POOR DEVELOPMENTAL OUTCOMES IN CHILDREN PRENATALLY EXPOSED TO SARS-COV-2: A SYSTEMATIC REVIEW
by: Marcio Leyser, et al.
Published: (2021-05-01)

Effectiveness of ayurvedic formulation, NAOQ19 along with standard care in the treatment of mild-moderate COVID-19 patients: A double blind, randomized, placebo-controlled, multicentric trial
by: Pankaj Bhardwaj, et al.
Published: (2023-11-01)

Nucleoside Analogs and Nucleoside Precursors as Drugs in the Fight against SARS-CoV-2 and Other Coronaviruses
by: Nicola Borbone, et al.
Published: (2021-02-01)

A Novel Frameshifting Inhibitor Having Antiviral Activity against Zoonotic Coronaviruses
by: Dae-Gyun Ahn, et al.
Published: (2021-08-01)

SARS-CoV-2 mRNA Vaccines Elicit Different Responses in Immunologically Naïve and Pre-Immune Humans
by: David Forgacs, et al.
Published: (2021-09-01)